Description of Research: Sandro Cinti

Bioterrorism/Emerging Infections

Dr. Cinti is an infectious diseases physician with ongoing involvement in the preparation for bioterrorism and emerging infections at the national, state and local level. He has been a member of the State of Michigan Bioterrorism Subcommittee since its inception in 1999 and is an external reviewer for the Communicable Diseases Plan being developed by the Michigan Department of Community Health. Dr. Cinti is also a member of the Washtenaw County Bioterrorism Subcommittee and the Michigan Infectious Diseases Society Bioterrorism Subcommittee (MIDS). Both of these committees comprise experts from many different disciplines (public health, fire, police, HAZMAT). Dr. Cinti is also a member of the University of Michigan Disaster Committee that developed a hospital-wide plan for responding to a bioterrorism event. Currently, Dr. Cinti is co-chairman of the Region 2 South Communicable Diseases Planning Team (formerly the Smallpox Response Planning Team) and a member of the Region 2 South Advisory Committee. Dr. Cinti is the Director of the Michigan Biodefense Alert Listserv (MBAL) which was initially created with a grant from the Michigan Department of Community Health (MDCH). MBAL, now located at the Michigan State Medical Society, is a clinician network that serves as a conduit of information on bioterrorism and emerging infections as well as a biosurveillance tool. Dr. Cinti disseminates postings over the listserv on topics relevant to the care of patients exposed to biological agents or emerging infections (SARS, WNV).

At the national level, Dr. Cinti sits on the Board of Directors of the National Center for Critical Incident Analysis (NCCIA). This group convenes a yearly session involving national experts in public health, medicine, public policy, the media, and law enforcement. These sessions explore ways that diverse groups can better respond to critical incidents. NCCIA has developed a model to explore critical incidents in a more systematic manner. This model will be published in the next year.

Dr. Cinti has experience in teaching and training groups to respond to bioterrorism. He has developed a one week course (Epidemiology 776) that is offered at the Summer Epidemiology Program at the University of Michigan. He has developed a similar course for the yearly Michigan State Medical Society (MSMS) meeting. Also, Dr. Cinti teaches yearly bioterrorism classes to 1st and 2nd year medical and dental students. Dr Cinti has convened several bioterrorism response panels for environmental journalist conferences in New Orleans, LA and Lansing, MI.

HIV/AIDS

Dr. Cinti also participates in HIV/AIDS clinical research. He is site PI of a tri-national study involving the VA Medical system that is looking at structured treatment interruptions and mega-HAART regimens. He has published on the topic of adherence to antiretroviral regimens and recently completed a pilot study looking at automated telephone calls as a way of improving adherence to HIV antiretrovirals. Dr. Cinti is a member of the UM HIV/AIDS clinical team and he is the clinical lead of the HIV/AIDS clinic at the Ann Arbor VA which cares for 150 HIV patients.

Recent Publications

Cinti, SK; Gandhi, T; Riddell, J. Non-AIDS-defining cancers: Should antiretroviral therapy be initiated earlier? AIDS Read 18 (1): 18, 2008.

Nicolasora N, Cinti SK, Riddell J, Kauffman CA. A 53-year-old man with a large air bubble in his chest. Diagnosis: Bronchopleural fistula and hydropneumothorax caused by coccidioidomycosis (Photo Quiz). Clin Infect Dis 47 (6): 823-824, 2008.

Cinti SK, Wilkerson W, Holmes JG, Shlafer J, Kim C, Collins CD, Bandy K, Krupansky F, Lozon M, Bradin SA, Wright C, Goldberg J, Wagner D, Rodgers P, Atas J, Cadwallender B. Pandemic Influenza and Acute Care Centers: Taking Care of Sick Patients in a Nonhospital Setting. Biosecurity Bioterrorism-Biodefense Strategy Practice Science 6 (4): 335-348, 2008.

Damuth E, Heidelbaugh J, Malani PN, Cinti SK. An Elderly Patient with Fluoroquinolone-Associated Achilles Tendinitis. Amer J Geriatr Pharmacother 6 (5): 264-268, 2008.

Chaiyachati K, Cinti SK, Kauffman CA, Riddell J. HIV-Infected patients with anal carcinoma who subsequently developed oral squamous cell carcinoma: Report of 2 cases. J Intl Ass Phys AIDS Care 7:306-11, 2008.

Cinti SK, Barnosky AR, Gay SE, Goold SD, Lozon MM, Kim K, Rodgers PE, Baum NM, Cadwallender BA, Collins CD, Wright CM, Winfield RA. Bacterial Pneumonias during an influenza pandemic: How will we allocate antibiotics? Biosec Bioterr-Biodefense Strat Pract Sci 7 (3): 311-316, 2009.

Agarwal PP, Cinti S, Kazerooni EA. Chest Radiographic and CT Findings in Novel Swine-Origin Influenza A (H1N1) Virus (S-OIV) Infection. Am J Roentgenol 193 (6): 1488-1493, 2009.

Kim CS, Pile JC, Lozon MM, Wilkerson WM, Wright CM, Cinti S. Role of Hospitalists in an Offsite Alternate Care Center (ACC) for Pandemic Flu. J Hosp Med 4 (9): 546-549, 2009.

Napolitano LM, Park PK, Sihler KC, Papadimos T, Chenoweth C, Cinti S, Zalewski C, Sharangpani R, Somsel P, Wells E, Fry AM, Fiore AE, Lindstrom S, Uyeki TM. Intensive-care patients with severe novel influenza (H1N1) virus infection –Michigan, June 2009. MMWR 58;749-52.

Cinti S. Chikungunya fever: An emerging infection. Infect Dis Clin Practice. 2009;17:6-11.

Cinti S. "Medical marijuana in HIV+ patients: What do we do now?". J Intl Ass Phys AIDS Care. 2009, 8(6);342-347.

Nichani S, Cinti S, Barsuk JH. "Making a List and Checking It Twice". J Hosp Med 6 (4): 233-237, 2011.

Cinti S, Haas K, Paliani P, Newton D, Wright C, Zalewski C, Holmes JG, Dwyer S, Friedman C, Chenoweth C. Efficacy of Surveillance for 2009 H1N1 Pandemic within a Healthcare System. Infect Contr Hosp Epidemiol 32 (8): 811-814, 2011.